CORRECTING and REPLACING Tel-Instrument Electronics Corp. Reports Net Income of $1.0 Million for Second Quarter 2022
The updated release reads:
Highlights include:
-
Revenues for the second quarter increased to
, an$3.6 million 8% increase from the year-ago quarter. -
Gross margin percentages improved
46.2% due to manufacturing efficiencies, tight cost controls, and product mix pricing. -
Quarterly operating expenses increased
25% to due to higher engineering and higher profit-sharing accruals.$1.3 million -
Operating income increased to
for the current quarter as compared to$385 K in the year ago quarter.$342 K -
Six month operating income increased to
versus$1,151 K in the year-ago period.$551 K -
The Company received full loan forgiveness on the
second draw PPP loan.$722 k -
Net income increased to
, or$1.0 million per common share and$0.28 per share on a fully diluted basis.$0.20 -
Cash balances improved to
, compared to$6.8 million at the start of the fiscal year.$5.5 million -
Net worth improved to
compared to$6.6 million at the start of the fiscal year.$5.2 million
Mr. Jeffrey O’Hara, Tel-Instrument’s President and CEO commented, “The Company recorded a profitable second quarter despite ongoing supply chain interruptions which have hampered our production. With the recent forgiveness of the PPP loan, we now have zero debt and a growing cash balance which has allowed us to continue our aggressive engineering programs such as the SDR/OMNI. We have started to market this product to key customers with production and deliveries expected to commence in the first quarter of calendar year 2022. We believe that this will be a strong competitor in both commercial and military markets. We were informed this week that the Lockheed Martin has lifted the stop work order on the MADL program. This will generate non-recurring engineering revenues over the next two quarters and should result in ongoing production revenues in what is essentially a new market for TIC. We are also actively working with the
“With respect to the Aeroflex litigation, we continue to believe that we have strong grounds for the award to be vacated or reduced. The appeal process has been delayed due to the COVID-19 pandemic, but we expect a decision within the next 12 months.”
About
Tel-Instrument is a leading designer and manufacturer of avionics test and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. Tel-Instrument provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. For further information please visit our website at www.telinstrument.com.
This press release includes statements that are not historical in nature and may be characterized as “forward-looking statements,” including those related to future financial and operating results, benefits, and synergies of the combined companies, statements concerning the Company’s outlook, pricing trends, and forces within the industry, the completion dates of capital projects, expected sales growth, cost reduction strategies, and their results, long-term goals of the Company and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. All predictions as to future results contain a measure of uncertainty and, accordingly, actual results could differ materially. Among the factors which could cause a difference are: changes in the general economy; changes in demand for the Company’s products or in the cost and availability of its raw materials; the actions of its competitors; the success of our customers; technological change; changes in employee relations; government regulations; litigation, including its inherent uncertainty; difficulties in plant operations and materials; transportation, environmental matters; and other unforeseen circumstances. A number of these factors are discussed in the Company’s previous filings with the
|
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
|
|
2021 |
|
|
2021 |
|
||
|
|
(unaudited) |
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
4,808,457 |
|
|
$ |
3,485,275 |
|
Accounts receivable, net |
|
|
1,530,060 |
|
|
|
1,933,321 |
|
Inventories, net |
|
|
2,910,721 |
|
|
|
3,437,989 |
|
Restricted cash to support appeal bond |
|
|
2,011,050 |
|
|
|
2,011,050 |
|
Prepaid expenses and other current assets |
|
|
188,127 |
|
|
|
263,067 |
|
Total current assets |
|
|
11,448,415 |
|
|
|
11,130,702 |
|
|
|
|
|
|
|
|
|
|
Equipment and leasehold improvements, net |
|
|
142,277 |
|
|
|
200,769 |
|
Operating lease right-of-use assets |
|
|
1,815,304 |
|
|
|
1,922,805 |
|
Deferred tax asset, net |
|
|
2,443,042 |
|
|
|
2,675,040 |
|
Other long-term assets |
|
|
35,109 |
|
|
|
35,110 |
|
Total assets |
|
$ |
15,884,147 |
|
|
$ |
15,964,426 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES & STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Operating lease liabilities – current portion |
|
$ |
190,622 |
|
|
$ |
201,883 |
|
Accounts payable |
|
|
391,247 |
|
|
|
906,149 |
|
Deferred revenues - current portion |
|
|
149,223 |
|
|
|
150,709 |
|
Accrued expenses ‐vacation pay, payroll and payroll withholdings |
|
|
342,170 |
|
|
|
457,232 |
|
Accrued legal damages |
|
|
5,993,433 |
|
|
|
5,889,023 |
|
Accrued expenses - other |
|
|
235,310 |
|
|
|
365,975 |
|
Total current liabilities |
|
|
7,302,005 |
|
|
|
7,970,971 |
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities – long-term |
|
|
1,624,682 |
|
|
|
1,720,921 |
|
Long term debt - PPP |
|
|
- |
|
|
|
722,577 |
|
Deferred revenues – long-term |
|
|
312,420 |
|
|
|
332,428 |
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
9,239,107 |
|
|
|
10,746,897 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Preferred stock, 1,000,000 shares authorized, par value |
|
|
|
|
|
|
|
|
Preferred stock, 500,000 shares
issued and outstanding, par value |
|
|
3,695,998 |
|
|
|
3,695,998 |
|
Preferred stock, 166,667 shares
issued and outstanding, par value |
|
|
1,147,367 |
|
|
|
1,147,367 |
|
Common stock, 7,000,000 shares authorized, par value 3,255,887 shares issued and outstanding, respectively |
|
|
325,586 |
|
|
|
325,586 |
|
Additional paid-in capital |
|
|
7,170,954 |
|
|
|
7,318,620 |
|
Accumulated deficit |
|
|
(5,694,865 |
) |
|
|
(7,270,042 |
) |
Total stockholders’ equity |
|
|
6,645,040 |
|
|
|
5,217,529 |
|
Total liabilities and stockholders’ equity |
|
$ |
15,884,147 |
|
|
$ |
15,964,426 |
|
|
||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
3,610,863 |
|
|
$ |
3,336,396 |
|
|
$ |
7,743,256 |
|
|
$ |
6,275,833 |
|
Cost of sales |
|
|
1,942,956 |
|
|
|
1,969,573 |
|
|
|
4,060,602 |
|
|
|
3,404,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
1,667,907 |
|
|
|
1,366,823 |
|
|
|
3,682,654 |
|
|
|
2,871,434 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
596,618 |
|
|
|
464,809 |
|
|
|
1,150,651 |
|
|
|
1,126,060 |
|
Litigation expenses |
|
|
3,220 |
|
|
|
5,514 |
|
|
|
4,400 |
|
|
|
8,210 |
|
Engineering, research, and development |
|
|
682,852 |
|
|
|
554,555 |
|
|
|
1,376,427 |
|
|
|
1,186,508 |
|
Total operating expenses |
|
|
1,282,690 |
|
|
|
1,024,878 |
|
|
|
2,531,478 |
|
|
|
2,320,778 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
385,217 |
|
|
|
341,945 |
|
|
|
1,151,176 |
|
|
|
550,656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
995 |
|
|
|
1,879 |
|
|
|
1,980 |
|
|
|
4,725 |
|
Other income |
|
|
22,260 |
|
|
|
- |
|
|
|
35,853 |
|
|
|
13,854 |
|
Gain on forgiveness of PPP loan |
|
|
722,577 |
|
|
|
- |
|
|
|
722,577 |
|
|
|
- |
|
Interest expense – judgement |
|
|
(52,490 |
) |
|
|
(52,490 |
) |
|
|
(104,410 |
) |
|
|
(127,634 |
) |
Interest expense |
|
|
- |
|
|
|
(9,380 |
) |
|
|
- |
|
|
|
(19,160 |
) |
Total other net income, (expense) |
|
|
693,342 |
|
|
|
(59,991 |
) |
|
|
656,000 |
|
|
|
(128,215 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
1,078,559 |
|
|
|
281,954 |
|
|
|
1,807,176 |
|
|
|
422,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
78,883 |
|
|
|
59,206 |
|
|
|
231,999 |
|
|
|
88,713 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
999,676 |
|
|
|
222,748 |
|
|
|
1,575,177 |
|
|
|
333,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividends |
|
|
80,000 |
|
|
|
80,000 |
|
|
|
160,000 |
|
|
|
160,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common shareholders |
|
$ |
919,676 |
|
|
$ |
142,748 |
|
|
$ |
1,415,177 |
|
|
$ |
173,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per common share |
|
$ |
0.28 |
|
|
$ |
0.04 |
|
|
$ |
0.43 |
|
|
$ |
0.05 |
|
Diluted income per common share |
|
$ |
0.20 |
|
|
$ |
0.04 |
|
|
$ |
0.31 |
|
|
$ |
0.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
3,255,887 |
|
|
|
3,255,887 |
|
|
|
3,255,887 |
|
|
|
3,255,887 |
|
Diluted |
|
|
5,095,665 |
|
|
|
5,068,949 |
|
|
|
5,095,665 |
|
|
|
3,255,887 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005425/en/
(201) 933-1600
Source: